Insurance

All you need to know about the new integrated shield riders

All customers have automatically been switched to the new integrated shield riders from 1 April 2021. In this article, we highlight the differences between the riders and show how this will affect you.

  • Phuan Wei Ning
  • |
  • Published on 12 May 2021

With full riders that cover the entire co-payment in Integrated Shield (IP) riders resulting in 60 per cent higher medical bills, the Ministry of Health (MOH) announced a new requirement for IP riders in 2018. This will require insurers to incorporate a co-payment feature in new Integrated Shield riders, thus removing the option of a full rider with zero co-payment.1

While this requirement was announced in 2018, insurers were given time to work out the new riders and transit their policyholders to the new riders. Therefore, from 1 April 2021 all policyholders will be transited to the new IP riders. In this article, we highlight the three main changes to NTUC Income’s Enhanced Incomeshield rider and how this will affect you as a policyholder.

(See "Are Integrated Shield Plans Necessary?")


#1 Co-payment is now necessary even with a rider

One of the main changes to Income’s Enhanced Incomeshield is the rider. From 1 April 2021, all Plus and Assist riders from NTUC Income will no longer be available for policy renewals. Instead, individuals who are still on the old Plus and Assist riders will have their riders automatically switched to the new Deluxe Care and Classic Care rider respectively.

Previously, individuals with the Plus rider were able to obtain full coverage against hospital bills with no co-payment required. However, going forward this will no longer be available. Instead, policyholders will have to pay out-of-pocket expenses of at least 5 per cent of their hospital bill.

For those who were previously on Assist rider, they will automatically be switched to Income’s Classic Care rider with the same 10 per cent co-payment required for their hospital bill.

Old rider
Co-payment required by old rider for treatment
New rider that policy holders will automatically be switched to
Co-payment required by new rider for treatment
Plus rider
0%
Deluxe Care rider
5%
Assist rider
10%
Classic Care rider
10%

(See "Our honest opinions about CareShield Life and its supplements")


#2 Panel and non-panel treatment

Another new feature is the introduction of panel and non-panel doctors. Under the new riders, policyholders will be eligible for a co-payment cap of up to $3,000 per policy year if they seek treatment from the insurer’s panel healthcare providers. While there will still be a 5 or 10 per cent co-payment required, this cap will put a limit on the maximum out-of-pocket expenses required by the policyholder.

However, should policyholders choose to receive treatment at non-panel providers, there will not be a cap for co-payment. Non-panel charges of up to $2,000 per policy year will also apply for Classic Care rider.

Benefit payable from the new Deluxe Care and Assist Care riders:

This new feature is meant to encourage policyholders to receive treatment at panel providers. Doing so will limit their out-of-pocket expenses to no more than $3,000 per policy year for both Deluxe Care rider and Classic Care rider.

(Old) Plus rider
(New) Deluxe Care rider
(Old) Assist rider
(New) Classic Care rider
For panel providers
Co-payment for treatment by panel providers
0%
5%
10%
10%
Cap on co-payment for panel treatments
N.A.
$3,000 per policy year
$1,500 to $3,000 per policy year with this differing between plans
$3,000 per policy year
For non-panel providers
Co-payment for treatment by non-panel providers
0%
5%
10%
10%
Cap on co-payment for non-panel treatments
N.A.
No cap for non-panel
$1,500 to $3,000 per policy year with this differing between plans
No cap for non-panel
Additional non-panel payment
-
-
-
Up to S$2,000 per policy year on top of co-payment

Do note that the main treatment must be provided by the panel provider in order for the claim to be considered as panel and have a co-payment limit. This also applies to pre/post hospitalisation treatment and special benefit claims.

(See "Don't Need A Full Critical Illness Plan? Here's Your Alternative")


#3 Hospital cash benefit

The hospital cash benefit refers to a fixed amount that the policyholder will receive if he is admitted to a ward that is lower than the ward his plan entitles him to. For example, a policyholder will receive this hospital cash benefit if he has a plan that covers for Class A ward but choose to stay at a Class B1/B2 ward. This is given on top of the policyholder’s existing medical benefits.

While both Plus and Assist riders used to offer this hospital cash benefit, this will no longer be available in the new Deluxe Care and Classic Care riders. Policyholders will therefore not be entitled to any additional cash benefits for choosing to stay in a lower class ward.

(See "Fixed or Renewable – Which is the better term insurance?")


What these changes mean to us

These changes to Income’s Enhanced Incomeshield riders are likely to result in higher out-of-pocket expenses for us. This is because full riders are no longer available with a minimum 5 per cent co-payment now required for our medical bills.

Additionally, policyholders are also encouraged to opt for panel clinics so as to enjoy less out of pocket expenses. This may impose some limitations on the flexibility to choose your own preferred doctor.

Average Bill at a private hospital
Amount payable under OLD Plus Rider (No co-payment)
Amount payable under NEW Deluxe Care Rider (5% co-payment)
Amount payable under OLD Assist Rider*
Amount payable under NEW Assist Care Rider (10% co-payment)
Panel
Non-Panel
Panel
Non-Panel
Co-payment
-
0%
5%
5%
10%
10%
10%
Co-payment limit
-
N.A.
$3,000 per policy year
No limit
$3,000* per policy year
$3,000 per policy year
No limit
Non-panel charges
-
N.A.
N.A.
N.A.
N.A.
N.A.
$2,000 per policy year
Endoscopy
$6,000^
$0
$300
$300
$600
$600
$2,600
Breast Cancer
$500,000^
$0
$3,000
$25,000
$3,000
$3,000
$52,000

*Assuming coverage for Income Enhanced Preferred plan

^Information shown are based on the private bill size of 2019 incurred claims for policyholders with NTUC Income’s Plus and Assist Riders.


With changes to integrated shield riders, are these riders still worth obtaining? In our next article "Disappointed with the new integrated shield riders? This is what we think", we explore some alternatives for hospitalisation coverage.


If you would like to find out more about the changes or would like a second opinion on whether you should make any changes to your hospital plan, you may contact us here. At FSMOne, we also offer commission rebates for life insurance products, speak to our advisers if you would like to find out more.


Over 10,300 users trust FSMOne with their insurance planning

Live better, safer. Take risks with your investments, not your insurance.

Speak to our experts today to get proper protection.

Get Started


Click here to find out how much protection you need


Available Products on FSMOne Insurance

Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial)


from AIG, Allianz, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Manulife, NTUC Income, QBE, Sompo and Tokio Marine Life Insurance


*Please check with our advisory team if the product you want is available on FSMOne Insurance


Interested to learn more? Check out these articles:

4 Tips For Your Next Home Insurance Purchase

When is a renewable term insurance the better option?

How much should I be spending on insurance for my child?

Should I switch from Eldershield to CareShield Life?

What should I do with my maturing endowment plan?


----

1Source: https://www.moh.gov.sg/docs/librariesprovider5/pressroom/current-issues/cos-2018-media-factsheet---keeping-healthcare-costs-sustainable-for-all-singaporeans.pdf

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.


Ways to Invest with FSM Global
Why FSM Global
Don't have an account with us?
Open an account here
Need Financial Advice?
Make an appointment
Related Articles More

We use cookies If you close this message or continue to use this site, you will consent to the use of Cookies, unless you choose to disable them. Click on our Privacy Policy to understand more.